This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Case for Investing in U.S. in 2011

Stocks in this article: BACCBACATAPOLXOMPG

The Political Landscape Turns Favorable

It's no secret that political powers took a toll on financial, health-care and education sectors as government officials turned the industries into dartboards.

As the chart above shows, key education, financial and health-care stocks are down sharply this year.

But that was 2010. In the coming year -- the third of President Barack Obama's four-year term -- stocks are expected to outperform as political pressures bode well for equities.

"If you want to run for re-election, you care about the year you're running in," Cantor Fitzgerald's Pado says. "In order to make things good in year four, you have to get things going in year three. It takes a year before whatever fiscal or monetary measures show their full benefit."

It's not quite 2011 yet, but Americans have already seen Obama push for extending the Bush-era tax cuts in a bipartisan surprise. Additionally, the president has pushed for a $120 billion reduction to the Social Security tax.

Dearborn Partners' Nolte warns investors not to get too caught up in the excitement of the extension of the tax cuts.

"The Bush tax cuts do nothing because it's status quo," he says. "It avoids the negative change that we would've seen, but it doesn't necessarily improve anything. At the margin, they have changed some of the Social Security withholding. But they didn't do it on the corporate side, so if someone hires you, they'll have to pay what they had to pay before.

Nolte goes a step further and suggests the impact of politics is hard to handicap. "The political environment moves so slowly," he says. "Even if you look at ObamaCare, it took well over a year to finally come to fruition. While we can speculate now as to what might happen, there will be lots of time before anything gets done."

Auxier of the Auxier Focus Fund is willing to take on the risks of political pressure if others aren't. He has been buying a basket of education and medical-device stocks, which he finds compelling.

On the education side, he's focused on Strayer Education (STRA) , Apollo Group (APOL) and Career Education (CECO), noting that the sector is "really hated. It's been attacked, and it's really cheap."

Medtronic (MDT) and Abbott Labs (ABT) , meanwhile, are in Auxier's group of medical-device stocks, which he calls "hopelessly out of favor" like the education companies.

"It's a reversion to the mean," he says. "It's like BP (BP), which we bought on the way down. You want to make sure, though, that these companies have the balance sheets to endure so you can get into some quality businesses that historically have higher premiums."

-- Written by Robert Holmes in Boston.



>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
5 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,671.42 +210.10 1.28%
S&P 500 1,952.04 +24.93 1.29%
NASDAQ 4,453.4320 +70.5850 1.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs